Target intelligence / Profile preview

High-mobility group box 2 pseudogene (HMGB1P43)

Target
HMGB1P43
Molecular classification
Pseudogene, Other (not classified as receptor, enzyme, transporter, transcription factor, etc.)
01

Overview

High-mobility group box 2 pseudogene (HMGB1P43, ENSG00000271044) is a genomic DNA sequence classified as a pseudogene due to its homology to the protein-coding HMGB2 gene. Unlike the functional HMGB2 gene, which encodes a non-histone chromatin-binding protein involved in DNA bending, repair, and regulation of gene expression, HMGB1P43 does not produce a functional protein or play a known direct role in biological processes. Pseudogenes such as HMGB1P43 typically lack regulatory elements and accumulate disabling mutations, rendering them nonfunctional. While some pseudogenes have been implicated in regulatory RNA networks or as sources of novel genetic material, there is no indication that HMGB1P43 has such functions[3][5][7]. The "high-mobility group box 2 pseudogene" (ENSG00000271044, HMGB1P43) is a nonfunctional pseudogene and not a valid therapeutic target. It does not encode a protein, does not have known biological functions or disease roles, is not acted on by drugs, and does not serve as a biomarker. The listing as a target is incorrect with respect to therapeutic relevance[3][5][7].

Other names
high-mobility group box 2 pseudogeneHMGB1P43ENSG00000271044
02

Mechanism of action

None applicable. Drugs do not target pseudogenes for therapeutic effect

03

Biological functions

None established. Most pseudogenes do not have a biological function; rarely, some pseudogene transcripts may modulate gene expression or act as noncoding RNAs, but there are no specific reports of HMGB1P43 function
04

Disease associations

None established. Pseudogenes occasionally are implicated in regulatory RNA networks in disease, but there is no evidence that this gene has any disease association
05

Safety considerations

None specific. Pseudogenes do not pose safety concerns or therapeutic challenges
06

Interacting drugs

None. Pseudogenes do not interact with drugs, as they lack a protein product or regulatory role relevant to drug action
07

Biomarkers

None. Not used as a biomarker for patient selection or efficacy monitoring

Beyond the preview

Go deeper on High-mobility group box 2 pseudogene (HMGB1P43).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on High-mobility group box 2 pseudogene (HMGB1P43).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call